Effectiveness and Safety of Yiqitongluo Granule for Stroke

Enrolling by invitation

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- mild and moderate ischemic stroke patient with 4-25 NIHSS score
- stable patients within 1 week to 3 months
- sign informed consent before study

Exclusion Criteria

- CT shows cerebral hemorrhage disease: such as hemorrhagic stroke, epidural hematoma, intracranial hematoma, ventricular hemorrhage, and subarachnoid hemorrhage
- severe disturbance of consciousness
- dysphagia
- hemorrhagic diathesis
- patient with malignant tumor whose expected lifetime is less than 3 months
- allergic constitution
- gestation period, lactation period, woman with the possibility or plan of pregnancy
- those who participated in other clinical trials within 3 months or taking part in other clinical trials